A Real World Research: Comparison of Precision and Experience Therapy for Hypertension, Diabetes or Hyperlipidemias (RCG)
Hypertension,Essential, Diabetes type2, Hyperlipidemias
About this trial
This is an interventional supportive care trial for Hypertension,Essential
Eligibility Criteria
Inclusion Criteria:
- They are 55 years old or above, with no gender restriction. They are permanent residents of Da-jie town and Jiu-zhi Township in Da-ming County.
Patients who meet one of the following:
A. Hypertension project group:
Primary hypertension was definitely diagnosed, systolic blood pressure ≥ 140 millimeter of mercury, diastolic blood pressure ≥ 90 millimeter of mercury, or both after drug treatment.
B.Type 2 Diabetes project group:
Patients with type 2 diabetes mellitus (non insulin dependent diabetes mellitus) who were diagnosed as type 2 diabetes mellitus (NIDDM) and had HbA1c ≥ 7.0% after drug treatment before enrollment.
C.Hyperlipidemia project group:
Those who were diagnosed as hyperlipidemia and were treated with or without medication before enrollment.
- Patients who can provide real and reliable information related to drug treatment and efficacy evaluation
Exclusion Criteria:
- Respondents who are not willing to fill in the true and reliable information form for any reason.
- Patients with infectious diseases or serious life-threatening diseases such as malignant tumors.
- Patients with severe liver and kidney function damage, affecting the choice of treatment drugs.
- Patients with incomplete data related to study evaluation such as any of following:
A.The clinical data did not include systolic blood pressure, diastolic blood pressure, heart rate, glycosylated hemoglobin, fasting blood glucose, total cholesterol, low-density lipoprotein cholesterol, high-density lipoprotein cholesterol, triglyceride core efficacy evaluation indicators.
B.The data related to adverse reactions required by clinical research can not be collected, including but not limited to the related drugs with adverse reactions, adverse reaction performance, time correlation, whether to stop suspicious drugs, and whether to stimulate adverse reactions by re-medication.
C.The information of medication compliance score and quality of life score could not be provided for any reason.
Sites / Locations
- Beijng Chao Yang Hospital
Arms of the Study
Arm 1
Arm 2
Arm 3
Experimental
Active Comparator
No Intervention
Precision group
Experience group
Observation group
The subjects were tested for gene, and the corresponding therapeutic drugs were selected according to the results of gene detection. Regular follow-up was conducted according to the study design to evaluate the efficacy and adverse reactions.
The subjects were treated with drugs selected by doctors according to their experience. Follow up was performed at the same frequency as the precision group to evaluate the efficacy and adverse reactions.
The subjects did not accept any intervention, including follow-up, especially regular evaluation of efficacy and adverse reactions.